MetLife, Inc.
MET
$69.20
$1.231.81%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 8.46% | 2.81% | 1.86% | 2.09% | 1.75% |
| Total Other Revenue | 18.27% | -73.16% | 303.19% | 202.77% | 148.30% |
| Total Revenue | 8.59% | 0.83% | 6.17% | 8.77% | 6.10% |
| Cost of Revenue | 10.50% | 2.59% | 1.60% | 1.68% | 0.81% |
| Gross Profit | 2.75% | -4.30% | 22.04% | 36.02% | 26.32% |
| SG&A Expenses | -- | -- | -- | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 6.83% | 4.61% | 3.24% | 2.56% | -17.20% |
| Total Operating Expenses | 9.83% | 2.96% | 1.89% | 1.84% | 1.15% |
| Operating Income | -6.06% | -21.17% | 85.26% | 222.23% | 151.25% |
| Income Before Tax | -17.09% | -4.96% | 53.39% | 101.05% | 160.04% |
| Income Tax Expenses | 6.79% | -24.02% | 79.36% | 153.05% | 110.36% |
| Earnings from Continuing Operations | -23.42% | 2.09% | 46.44% | 88.92% | 177.40% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -33.33% | 0.00% | 50.00% | 44.44% | 25.00% |
| Net Income | -23.66% | 2.10% | 47.37% | 90.44% | 180.48% |
| EBIT | -6.06% | -21.17% | 85.26% | 222.23% | 151.25% |
| EBITDA | -4.75% | -19.20% | 70.66% | 165.83% | 113.98% |
| EPS Basic | -20.99% | 7.16% | 59.31% | 111.17% | 226.16% |
| Normalized Basic EPS | -13.03% | -0.10% | 63.17% | 115.77% | 180.89% |
| EPS Diluted | -20.98% | 7.35% | 59.54% | 110.93% | 225.89% |
| Normalized Diluted EPS | -13.03% | -0.13% | 63.13% | 115.72% | 180.76% |
| Average Basic Shares Outstanding | -5.31% | -5.60% | -6.10% | -6.51% | -6.77% |
| Average Diluted Shares Outstanding | -5.32% | -5.58% | -6.06% | -6.46% | -6.72% |
| Dividend Per Share | 4.29% | 4.46% | 4.63% | 4.81% | 4.61% |
| Payout Ratio | 0.29% | -0.04% | -0.33% | -0.48% | -0.65% |